With the Myoril brand becoming a part of its portfolio, CORONA gains its first offering in the muscle relaxant category, strengthening its existing line up of more than 80 brands. The scientific expertise and market presence of Myoril in the muscle relaxant market complement Corona’s therapeutic enrichment efforts and strengthen its orthopaedic portfolio., With the Myoril brand becoming a part of its portfolio, CORONA gains its first offering in the muscle relaxant category, strengthening its existing line up of more than 80 brands. The scientific expertise and market presence of Myoril in the muscle relaxant market complement Corona’s therapeutic enrichment efforts and strengthen its orthopaedic portfolio., , Read More
AAS Yoga
Go for Euphoria – Illness to Wellness the Natural Way